Alkem Laboratories Limited

NSE:ALKEM.NS

5706.5 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009
Operating Activities:
Net Income 17,957.713,047.718,442.818,42112,597.99,546.69,259.89,646.38,4514,508.24,551.1475,099.0984,543.8233,552.0962,450.707
Depreciation & Amortization 2,9933,104.23,039.62,745.82,527.61,931.81,430.31,011.71,005.8709.4427.301360.152279.402270.461234.312
Deferred Income Tax 000-4,786.9-2,817.1-2,413.2-2,060.8-2,708.2-1,710.5000000
Stock Based Compensation 189.4001.11.55.86.53.70.2000000
Change In Working Capital -516.93,267.7-5,449.6-3,411.6-6,472-1,425.1-5,634.8-3,638.6136.8-723.9-2,468.3261,965.38-1,936.8956,393.444-2,842.639
Accounts Receivables -2,219.9-1,347.1-2,217.5-257.6-2,574.4-1,558.5-5,455.5-1,609-430.1-459.8-434.5-543000
Inventory -7344,734.1-6,731.4-4,977-2,817.4-373-2,356.5-3,034.7-1,181.2-909.4-717.093-1,457.223-692.134-522.148202.148
Accounts Payables 5,252.8145.13,344.92,124.2-37.4-109.52,939.61,959.62,178.5000000
Other Working Capital -2,815.8-264.4154.4-301.2-1,042.8615.9-3,278.3-603.91,318185.5-1,751.2333,422.603-1,244.7616,915.592-3,044.787
Other Non Cash Items 4,215.6-2,594.6-4,922.6-320.412.9128.2-239.2-616.6-624.8-1,239.1-1,452.062-1,868.015-1,701.654-1,215.05-683.308
Operating Cash Flow 20,962.316,82511,110.212,6495,850.87,774.12,761.83,698.37,258.53,254.61,058.065,556.6151,184.6769,000.951-840.928
Investing Activities:
Investments In Property Plant And Equipment -2,592.9-2,329.1-3,388.8-1,949.1-3,630.9-5,291.6-6,837.5-6,448.4-2,572-1,381.5-1,225.607-2,195.803-2,091.988-1,171.594-280.444
Acquisitions Net 724.832109104.6664.8460.267.11,337.137.4-2,074-2,499.269-534.234000
Purchases Of Investments -36,792.5-2,175.3-12,051.1-9,286.2-4,936.6-10.10-416.50-1,405.8306.401-1,519.987-3,085.76100
Sales Maturities Of Investments 26,180.94,129.8-109-104.6482.71,694.72,304.22,639.82,392.51,028.33,633.5152,235.972000
Other Investing Activites -7,492.11,4711,088.61,249.96.55.3859.628.72,043.71,463.4154.7851,612.4391,206.027722.186699.918
Investing Cash Flow -12,479.71,128.4-14,351.3-9,985.4-7,413.5-3,141.5-3,673.7-2,859.31,864.2-2,369.6369.825-401.613-3,971.722-449.408419.474
Financing Activities:
Debt Repayment -4,808.9-12,784.8-192.9-387.4-6,030.7-1,057.3-3,574.2-506.2-6,840.1-1,082.2-383.61-349.03000
Common Stock Issued 01,614.800000.600000000
Common Stock Repurchased 011,1700000000000000
Dividends Paid -5,380.4-5,295.2-4,219.1-3,347.8-4,395.6-2,185.8-2,175.9-863.4-1,845-566.7-318.563-517.053-209.137-209.137-174.856
Other Financing Activities -24.5-12,3138,207.71,017.711,217.8-546.33,020.91,003.8-587.61,131.1-842.741-792.15568.219-309.267-66.913
Financing Cash Flow -10,537-17,608.23,795.7-2,717.5791.5-3,789.4845.6-365.8-9,272.7-517.8-1,544.914-1,658.238-140.918-518.404-241.769
Other Information:
Effect Of Forex Changes On Cash -20.5712536.740.1-19.867.1-77.324.420.629.80.001-0.002-0.0030.001
Net Change In Cash 13,048.6416.2579.6-17.2-731.1823.40.8395.8-125.6387.8-117.0293,496.765-2,927.9668,033.136-663.222
Cash At End Of Period 15,793.52,7382,321.81,742.21,759.42,490.51,667.11,666.31,270.41,396172.8984,300.08411,308.37114,648.6926,615.556